4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001567619-22-002889
Options or other derivatives
- President acquired 283,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Beigelman Leonid President | 2022-02-04 | Grant or award · Stock Option (Right to Buy) | +226,800 | 226,800 | D | ||
| Beigelman Leonid President | 2022-02-04 | Grant or award · Stock Option (Right to Buy) | +56,700 | 56,700 | D | ||
Loading xslF345X03/doc1.xml…